The government is trying to revive the AYUSH sector, but the success of its measures would rest on its ability to establish AYUSH as an evidence-based sector
Following the successful first edition of Formulation and Drug Delivery (FDD) Conclave, The Indian Express (P) Ltd and Express Pharma recently hosted its second edition with the theme ‘Expanding...
After the lamp lighting ceremony, the dignitaries also released the FDD Leaders Handbook
Delivering a key note address at FDD Conclave on ‘Embracing complexity through drug delivery systems & innovation’, Dr Praveen Khullar, Head of Global Development Centre, Group Sanofi, Goa started...
Ranjit Barshikar, QbD/ cGMP Consultant & Member of Editorial Board, Journal of Generic Medicines, England gave a comprehensive presentation on the steps to implement Quality by Design in formulations
The speaker briefed the audience on inhalation drug delivery and capsule based dry powder inhalation (cPDI)
Alok Chandorkar, Market Development Manager-India, West Pharmaceutical Packaging India gave a presentation on 'Your Partner for Integrated Containment and Delivery Solutions' at FDD Conclave 2018
Audience at FDD Conclave 2018 interacting and checking out the products lauched by Ideal Cures
The first panel discussion at FDD Conclave 2018 was on Regulatory Pathways for Specialty/ Complex Generics
Day 2 of FDD Conclave 2018, began with a very insightful session titled, ‘Vaccine Delivery - An Emerging Opportunity’
Suresh Pareek, MD Ideal Cures, the presenting partner at FDD Conclave 2018, showcased an interesting offering, Ideal Cures Documented Solutions, before the leading professionals gathered at the event
The first panel discussion on Day 2 at FDD Conclave 2018 addressed the significance and need for integrated project management in formulation development and drug delivery
The last panel discussion of FDD Conclave 2018 was on the topic, '505(b)2: Avenues for Development'
The final presentation at FDD Conclave, titled 'Innovation in FDD: The way forward for India Pharma Inc', left the audience with a lot of food for thought
Experts and veterans of FR&D congregated for knowledge sharing galore at FDD Conclave 2018
The second edition of FDD Conclave was held at Novotel Airport, Hyderabad
Honours 21 R&D thought leaders and game changers for their significant contribution towards ushering innovation and progress in formulation development and drug delivery
The draft guideline of UCPMP restricts pharma companies from a lot of traditional marketing practices, however, it opens new doors of opportunity to leverage digital platform
There is an urgent need for concerted measures and renewed commitment from pharma companies and policy makers to halt the advance of drug pollution and its disastrous impact on...
Excipients make up more than 90 per cent of each pill or tablet we consume but have not been a major focus of regulators in the past. With a...
Vinod Arora, Principal Advisor Institute of Good Manufacturing Practices India–IGMPI, gives insights on ways to enable cGMP to assure safety and efficacy of drug products
Manne V Chowdhary, CEO & MD, AmpleLogic, elaborates on how to leverage digital technology to address regulatory challenges and to upgrade the verification and validation model in pharma companies
Rising levels of COPD, including asthma are driving a lot of innovations in Inhalers with an aim to improve the overall effective management of these diseases
Tabletting, one of the most essential processes in pharma manufacturing industry needs to undergo a metamorphosis to anticipate the changes coming its way and create capabilities to tackle opportunities...
It recognises excellence in pharma packaging and acknowledges the role of pharma packaging professionals in driving life sciences industry’s progress
The second day of the PPL Conclave began with an interesting panel discussion on Role of regulations: Assuring quality, safety, compliance and success with pharma packaging
Manoj Mishra, AVP- Sales & Marketing, UNIWORTH Enterprises LLP gave a presentation on ‘Introduction to pharma packaging’, wherein he spoke on his company’s offerings for the pharma sector